Luke Evnin - Net Worth and Insider Trading
Luke Evnin Net Worth
The estimated net worth of Luke Evnin is at least $26 Million dollars as of 2024-08-28. Luke Evnin is the Director of Pacira BioSciences Inc and owns about 824,255 shares of Pacira BioSciences Inc (PCRX) stock worth over $12 Million. Luke Evnin is the Director, 10% Owner of Harpoon Therapeutics Inc and owns about 452,443 shares of Harpoon Therapeutics Inc (HARP) stock worth over $10 Million. Luke Evnin is also the 10% Owner of Rigel Pharmaceuticals Inc and owns about 168,707 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $2 Million. Besides these, Luke Evnin also holds Conatus Pharmaceuticals Inc (CNAT) , Oncorus Inc (ONCR) . Details can be seen in Luke Evnin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luke Evnin has not made any transactions after 2020-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Luke Evnin
Luke Evnin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Luke Evnin owns 35 companies in total, including Turmeric Acquisition Corp (TMPMU) , Oncorus Inc (ONCR) , and Dyne Therapeutics Inc (DYN) among others .
Click here to see the complete history of Luke Evnin’s form 4 insider trades.
Insider Ownership Summary of Luke Evnin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TMPMU | Turmeric Acquisition Corp | 2020-10-15 | Chief Executive Officer |
ONCR | Oncorus Inc | 2020-10-06 | director & 10 percent owner |
DYN | Dyne Therapeutics Inc | 2020-09-16 | 10 percent owner |
![]() | ![]() | 2020-07-23 | 10 percent owner |
![]() | ![]() | 2020-06-18 | 10 percent owner |
![]() | ![]() | 2019-02-12 | director & 10 percent owner |
![]() | ![]() | 2019-02-13 | 10 percent owner |
![]() | ![]() | 2016-03-02 | director & 10 percent owner |
![]() | ![]() | 2017-10-04 | 10 percent owner |
![]() | ![]() | 2008-06-15 | 10 percent owner |
![]() | ![]() | 2015-10-14 | 10 percent owner |
![]() | ![]() | 2015-07-21 | 10 percent owner |
![]() | ![]() | 2014-05-07 | director |
![]() | ![]() | 2014-04-22 | 10 percent owner |
![]() | ![]() | 2014-03-10 | 10 percent owner |
![]() | ![]() | 2013-05-30 | 10 percent owner |
![]() | ![]() | 2013-07-24 | 10 percent owner |
![]() | ![]() | 2013-06-13 | director & 10 percent owner |
![]() | ![]() | 2012-08-11 | 10 percent owner |
![]() | ![]() | 2012-01-26 | other: Former 10% stockholder |
![]() | ![]() | 2011-10-27 | 10 percent owner |
![]() | ![]() | 2007-08-03 | other: See explanation below |
![]() | ![]() | 2010-09-30 | 10 percent owner |
![]() | ![]() | 2010-03-11 | 10 percent owner |
![]() | ![]() | 2010-01-27 | director & 10 percent owner |
![]() | ![]() | 2009-11-05 | 10 percent owner |
![]() | ![]() | 2004-07-28 | 10 percent owner |
![]() | ![]() | 2006-12-19 | 10 percent owner |
![]() | ![]() | 2003-12-17 | 10 percent owner |
![]() | ![]() | 2004-09-01 | 10 percent owner |
![]() | ![]() | 2004-03-10 | 10 percent owner |
![]() | ![]() | 2004-02-09 | 10 percent owner |
![]() | ![]() | 2021-10-28 | 10 percent owner |
![]() | ![]() | 2022-06-01 | director |
![]() | ![]() | 2020-10-15 | Chief Executive Officer |
Luke Evnin Latest Holdings Summary
Luke Evnin currently owns a total of 5 stocks. Among these stocks, Luke Evnin owns 824,255 shares of Pacira BioSciences Inc (PCRX) as of June 13, 2013, with a value of $12 Million and a weighting of 46.7%. Luke Evnin owns 452,443 shares of Harpoon Therapeutics Inc (HARP) as of February 12, 2019, with a value of $10 Million and a weighting of 40.74%. Luke Evnin also owns 168,707 shares of Rigel Pharmaceuticals Inc (RIGL) as of September 1, 2004, with a value of $2 Million and a weighting of 8.72%. The other 2 stocks Conatus Pharmaceuticals Inc (CNAT) , Oncorus Inc (ONCR) have a combined weighting of 3.84% among all his current holdings.
Latest Holdings of Luke Evnin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCRX | Pacira BioSciences Inc | 2013-06-13 | 824,255 | 14.48 | 11,935,212 |
HARP | Harpoon Therapeutics Inc | 2019-02-12 | 452,443 | 23.01 | 10,410,713 |
RIGL | Rigel Pharmaceuticals Inc | 2004-09-01 | 168,707 | 13.21 | 2,228,619 |
CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 1,192,080 | 0.56 | 667,565 |
ONCR | Oncorus Inc | 2020-10-06 | 2,492,843 | 0.13 | 314,098 |
Holding Weightings of Luke Evnin
Luke Evnin Form 4 Trading Tracker
According to the SEC Form 4 filings, Luke Evnin has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 22,746 shares on June 13, 2013, which brought Luke Evnin around $683,972.
According to the SEC Form 4 filings, Luke Evnin has made a total of 0 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years. The most-recent trade in Harpoon Therapeutics Inc is the acquisition of 25,000 shares on February 12, 2019, which cost Luke Evnin around $4 Million.
According to the SEC Form 4 filings, Luke Evnin has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 8,585 shares on September 1, 2004, which brought Luke Evnin around $2 Million.
More details on Luke Evnin's insider transactions can be found in the Insider Trading History of Luke Evnin table.Insider Trading History of Luke Evnin
- 1
Luke Evnin Trading Performance
GuruFocus tracks the stock performance after each of Luke Evnin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luke Evnin is 32.21%. GuruFocus also compares Luke Evnin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luke Evnin within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Luke Evnin's insider trading performs compared to the benchmark.
Luke Evnin Ownership Network
Ownership Network List of Luke Evnin
Ownership Network Relation of Luke Evnin
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Luke Evnin Owned Company Details
What does Turmeric Acquisition Corp do?
Who are the key executives at Turmeric Acquisition Corp?
Luke Evnin is the Chief Executive Officer of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Financial Officer Edward Hurwitz , President Todd Foley , and 10 percent owner Turmeric Management, Llc .
Turmeric Acquisition Corp (TMPMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turmeric Acquisition Corp Insider Transactions
Luke Evnin Mailing Address
Above is the net worth, insider trading, and ownership report for Luke Evnin. You might contact Luke Evnin via mailing address: The John Hancock Tower, 200 Clarendon Street, 54th Street, Boston Ma 02116.